Literature DB >> 5478542

Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid related to rated mental and motor impairment in senile and presenile dementia.

C G Gottfries, I Gottfries, B E Roos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5478542

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


× No keyword cloud information.
  7 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Authors:  P Hartikainen; H Soininen; K J Reinikainen; J Sirviö; R Soikkeli; P J Riekkinen
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 3.  Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment.

Authors:  C G Gottfries
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Monoamine acid metabolites in ventricular CSF of patients with brain tumours.

Authors:  S R Bareggi; M Porta; M Collice; G Calderini; M Ferrara; P L Morselli
Journal:  Acta Neurochir (Wien)       Date:  1976       Impact factor: 2.216

Review 5.  Monoamine neurons in aging and Alzheimer's disease.

Authors:  A M Palmer; S T DeKosky
Journal:  J Neural Transm Gen Sect       Date:  1993

6.  The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome.

Authors:  P C Burger; F S Vogel
Journal:  Am J Pathol       Date:  1973-11       Impact factor: 4.307

7.  Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.

Authors:  A M Palmer; N R Sims; D M Bowen; D Neary; J Palo; J Wikstrom; A N Davison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.